Reata Pharmaceuticals
RETA
$172.36
Share price
0.00%
Change (1 day)
373.78%
Change (1 year)
Categories
Reata Pharmaceuticals (RETA) - P/B ratio
P/B ratio as of May 2024 : 75.2
According to Reata Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 75.2.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Reata Pharmaceuticals - P/B ratio (from 2016 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | -21.2 | -510.69% |
| 2021-12-31 | 5.16 | -51.76% |
| 2020-12-31 | 10.7 | -59.52% |
| 2019-12-31 | 26.4 | -75.99% |
| 2018-12-31 | 110 | -2286.42% |
| 2017-12-31 | -5.03 | 121.92% |
| 2016-12-31 | -2.27 | |
| 2015-12-31 | N/A | |
| 2014-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.92 | -96.12% | 🇺🇸 USA |